Potential of mRNA-Based Gene TherapiesByJake Becraft, PhDOctober 23rd 2021Jake Becraft, PhD, chief executive officer and cofounder, Strand Therapeutics, discussed the company’s future research and plans.
Advantages of mRNA-Based Gene Therapies ByJake Becraft, PhDOctober 12th 2021Jake Becraft, PhD, chief executive officer and cofounder, Strand Therapeutics, discussed the company’s technology and focus on mRNA therapies.